Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFα signaling

被引:23
作者
Anderson, SP
Dunn, CS
Cattley, RC
Corton, JC
机构
[1] CIIT Ctr Hlth Res, Res Triangle Pk, NC 27709 USA
[2] N Carolina State Univ, Coll Vet Med, Grad Program Comparat Biomed Sci, Raleigh, NC USA
关键词
D O I
10.1093/carcin/22.11.1843
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rodents exposed to peroxisome proliferator xenobiotics respond with marked increases in hepatocellular replication and growth that results in tumor formation. Recently, tumor necrosis factor-alpha (TNF alpha) was proposed as the central mediator of this maladaptive response. To define the role of TNF alpha signaling in hepatocellular growth induced by peroxisome proliferators we administered three daily gavage doses of the potent peroxisome proliferator, Wy-14 643, to mice nullizygous for TNF-receptor I (TNFR1), TNFR2, or both receptors. We demonstrate here that regardless of genotype the mice responded with almost identical increases in liver to body weight ratios and hepatocyte proliferation. Lacking evidence that TNF alpha signaling mediates these effects, we then examined the possible contribution of alternative cytokine pathways. Semi-quantitative, reverse transcriptase polymerase chain reaction analysis revealed that wild type mice acutely exposed to Wy-14 643 had increased hepatic expression of Il1 beta, Il1r1, Hnf4, and Stat3 genes. Moreover, hepatic adenomas from mice chronically exposed to Wy-14 643 had increased expression of Il1 beta, Il1r1, Il6, and Ppary1. Expression of Il1 alpha, Tnf alpha, Tnfr1, Tnfr2, Ppar alpha, or C/ebp alpha was not altered by acute Wy-14 643 exposure or in adenomas induced by Wy-14643. These data suggest that the hepatic mitogenesis and carcinogenesis associated with peroxisome proliferator exposure is not mediated via TNFa but instead may involve an alternative pathway requiring IL1 beta and IL6.
引用
收藏
页码:1843 / 1851
页数:9
相关论文
共 80 条
  • [1] Anderson SP, 1999, MOL CARCINOGEN, V26, P226, DOI 10.1002/(SICI)1098-2744(199912)26:4<226::AID-MC2>3.0.CO
  • [2] 2-Q
  • [3] ANDERSON SP, 2000, TOXICOL SCI, V54, P420
  • [4] ANDERSON SP, 1998, TOXICOL PATHOL, V26, P838
  • [5] MECHANISTICALLY-BASED HUMAN HAZARD ASSESSMENT OF PEROXISOME PROLIFERATOR-INDUCED HEPATOCARCINOGENESIS
    ASHBY, J
    BRADY, A
    ELCOMBE, CR
    ELLIOTT, BM
    ISHMAEL, J
    ODUM, J
    TUGWOOD, JD
    KETTLE, S
    PURCHASE, IFH
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1994, 13 : S1 - S117
  • [6] THE ACUTE-PHASE RESPONSE
    BAUMANN, H
    GAULDIE, J
    [J]. IMMUNOLOGY TODAY, 1994, 15 (02): : 74 - 80
  • [7] Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
    Berthou, L
    Duverger, N
    Emmanuel, F
    Langouet, S
    Auwerx, J
    Guillouzo, A
    Fruchart, JC
    Rubin, E
    Denefle, P
    Staels, B
    Branellec, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2408 - 2416
  • [8] Bläker H, 1999, GENE CHROMOSOME CANC, V25, P399
  • [9] Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643
    Bojes, HK
    Germolec, DR
    Simeonova, P
    Bruccoleri, A
    Schoonhoven, R
    Luster, MI
    Thurman, RG
    [J]. CARCINOGENESIS, 1997, 18 (04) : 669 - 674
  • [10] Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1
    Bonizzi, G
    Piette, J
    Merville, MP
    Bours, V
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 59 (01) : 7 - 11